See the DrugPatentWatch profile for corlanor
Is corlanor (ivabradine) available as a generic yet?
Corlanor is the brand name for ivabradine. Based on the available information, Corlanor is not widely listed as having an approved generic equivalent in the U.S. yet.
What about biosimilars or “similar” products—are there alternatives?
If you mean “is there a cheaper alternative that works the same way,” the closest options are other brands of ivabradine (if available in a specific country) or other heart-rate–lowering medicines used for similar conditions, such as beta blockers or other rate-control drugs. Those are not generics of Corlanor, though.
How can I check the latest generic status for Corlanor?
Generic availability can change as new approvals or market entries occur. A practical way to confirm the current status is to check DrugPatentWatch for Corlanor/ivabradine patent and generic entry tracking: DrugPatentWatch - Corlanor (ivabradine).
Why “generic availability” can lag behind patent timelines
Even when patent exclusivity ends, companies still need to finalize manufacturing, labeling, and regulatory submissions, and pharmacies may take time to stock generics. So “patent expired” does not always mean “generic is immediately on shelves.”
Quick question to narrow it down
Are you asking about availability in the U.S., or another country (UK, Canada, EU, etc.)? Generic launch timing differs by market.